ijms-logo

Journal Browser

Journal Browser

Rheumatic Diseases: Molecular Mechanisms and Treatment

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (30 December 2024) | Viewed by 286

Special Issue Editor


E-Mail Website
Guest Editor
Department of Rheumatology and Clınıcal Immunology, University of Split, 21000 Split, Croatia
Interests: heumatology; systemic sclerosis; osteoarthritis; vasculitis; clinical immunology; clinical nutrition
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Rheumatic diseases encompass a diverse group of conditions characterized by autoimmune-mediated inflammation affecting multiple organs. Understanding their molecular mechanisms is crucial for developing effective treatments. Research has unveiled intricate pathways involving dysregulated immune responses, aberrant cytokine signaling, and genetic predispositions. Targeting these mechanisms has led to the development of innovative therapies such as biologic agents and small molecule inhibitors. Biologics like TNF-alpha inhibitors and interleukin-6 receptor antagonists disrupt inflammatory pathways, providing relief for conditions like rheumatoid arthritis and ankylosing spondylitis. Small molecule inhibitors, including Janus kinase (JAK) inhibitors, modulate intracellular signaling cascades to mitigate inflammation in diseases like psoriatic arthritis. Additionally, emerging treatments focus on immune regulation and tissue repair mechanisms to address the underlying pathology more effectively. By elucidating these molecular pathways and developing targeted therapies, researchers aim to improve outcomes and quality of life for individuals living with rheumatic diseases.

In this context, we anticipate and invite your submissions on, but not limited to, the following topics:

  1. Dysregulated immune responses and Immune modulation strategies in rheumatic diseases;
  2. Aberrant cytokine signaling and its role in rheumatic disease pathogenesis;
  3. Genetic predispositions and rheumatic disease susceptibility;
  4. Role of biologics Small molecule inhibitors in treating rheumatic diseases;
  5. The biomarkers, pathogenesis, and Targeted therapy of common rheumatic diseases (Rheumatoid arthritis, Systemic lupus erythematosus, Polymyositis and dermatomyositis, Sjögren’s syndrome, Osteoarthritis, etc.).

Dr. Mislav Radić
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • rheumatic disease
  • molecular mechanisms
  • treatment
  • cytokine signaling
  • tsDMARDs
  • anti-fibrotics
  • bDMARDs
  • genetic predispositions

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop